7-80638588-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000072.3(CD36):​c.-342G>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.325 in 144,078 control chromosomes in the GnomAD database, including 7,750 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.32 ( 7750 hom., cov: 23)
Exomes 𝑓: 0.25 ( 0 hom. )

Consequence

CD36
NM_000072.3 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.253

Publications

5 publications found
Variant links:
Genes affected
CD36 (HGNC:1663): (CD36 molecule (CD36 blood group)) The protein encoded by this gene is the fourth major glycoprotein of the platelet surface and serves as a receptor for thrombospondin in platelets and various cell lines. Since thrombospondins are widely distributed proteins involved in a variety of adhesive processes, this protein may have important functions as a cell adhesion molecule. It binds to collagen, thrombospondin, anionic phospholipids and oxidized LDL. It directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes and it binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Mutations in this gene cause platelet glycoprotein deficiency. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2014]
CD36 Gene-Disease associations (from GenCC):
  • platelet-type bleeding disorder 10
    Inheritance: AR Classification: STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.425 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000072.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CD36
NM_000072.3
c.-342G>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 14NP_000063.2A4D1B1
CD36
NM_000072.3
c.-342G>T
5_prime_UTR
Exon 1 of 14NP_000063.2A4D1B1
CD36
NM_001001547.3
c.-183-7500G>T
intron
N/ANP_001001547.1P16671-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CD36
ENST00000309881.11
TSL:1
c.-183-7500G>T
intron
N/AENSP00000308165.7P16671-1
CD36
ENST00000855951.1
c.-338G>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 15ENSP00000526010.1
CD36
ENST00000956951.1
c.-342G>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 15ENSP00000627010.1

Frequencies

GnomAD3 genomes
AF:
0.325
AC:
46782
AN:
143970
Hom.:
7753
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.255
Gnomad AMI
AF:
0.469
Gnomad AMR
AF:
0.301
Gnomad ASJ
AF:
0.334
Gnomad EAS
AF:
0.240
Gnomad SAS
AF:
0.443
Gnomad FIN
AF:
0.379
Gnomad MID
AF:
0.388
Gnomad NFE
AF:
0.360
Gnomad OTH
AF:
0.323
GnomAD4 exome
AF:
0.250
AC:
2
AN:
8
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
4
show subpopulations
African (AFR)
AF:
0.500
AC:
1
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2
European-Non Finnish (NFE)
AF:
0.250
AC:
1
AN:
4
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.750
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.325
AC:
46793
AN:
144070
Hom.:
7750
Cov.:
23
AF XY:
0.326
AC XY:
22774
AN XY:
69884
show subpopulations
African (AFR)
AF:
0.255
AC:
9936
AN:
38970
American (AMR)
AF:
0.301
AC:
4314
AN:
14340
Ashkenazi Jewish (ASJ)
AF:
0.334
AC:
1130
AN:
3382
East Asian (EAS)
AF:
0.239
AC:
1152
AN:
4818
South Asian (SAS)
AF:
0.442
AC:
1919
AN:
4346
European-Finnish (FIN)
AF:
0.379
AC:
3484
AN:
9196
Middle Eastern (MID)
AF:
0.379
AC:
106
AN:
280
European-Non Finnish (NFE)
AF:
0.360
AC:
23674
AN:
65842
Other (OTH)
AF:
0.329
AC:
659
AN:
2002
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
1442
2884
4327
5769
7211
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
476
952
1428
1904
2380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.301
Hom.:
2243
Bravo
AF:
0.313

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
1.0
DANN
Benign
0.40
PhyloP100
-0.25
PromoterAI
0.00080
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1334512; hg19: chr7-80267904; COSMIC: COSV59209686; COSMIC: COSV59209686; API